logo
Hummingbirds Are Evolving to Adapt to Life With Humans

Hummingbirds Are Evolving to Adapt to Life With Humans

WIRED29-05-2025

May 29, 2025 5:00 AM Anna's hummingbirds have evolved to have longer, larger beaks to access backyard feeders in urban areas. It could be a step toward becoming a 'commensal' species that lives alongside humans, like pigeons. A hummingbird drinking nectar from a feeder. Photograph: LAP/GETTY IAMGES
Some species of hummingbird are adapting to urban life by undergoing evolutionary changes in their anatomy, influenced by the proliferation of artificial drinking fountains. According to some biologists, this might show that these birds are on their way to becoming commensal with humans—benefiting from living closely alongside them—like pigeons have in urban areas.
A recent study found that the size and shape of the beaks of Anna's hummingbirds ( Calypte anna ), a species native to North America, have changed. A hummingbird's beak is naturally long and slender in order to access nectar located in deep inside flowers. However, in recent decades, the beaks of urban Anna's hummingbirds have evolved to be significantly longer and larger to better access sugar-laced drinking fountains installed outside of homes, which have proliferated in urban areas. This adaptation suggests that these feeders offer hummingbirds more food than nectar-filled flowers.
The study, which looked at reported sightings of the birds as well museum specimens from the past 160 years, also found that males are developing sharper, more pointed beaks, possibly to compete with other hummingbirds for access to these sugar-filled fountains.
Populations of these hummingbirds expanded northward in California at the same time as the establishment of urban centers where feeding could take place. The researchers discovered that the population density of Calypte anna has also increased over time, and found that this appears to be linked to the proliferation of feeding fountains and nectar-producing eucalyptus trees, both of which were introduced to the region by humans.
These morphological changes to the hummingbirds have occurred rapidly. According to the study, Calypte anna populations in 1930 were very different from those in 1950, when the birds' bills had already begun to grow. In just 20 years, equivalent to about 10 generations of these birds, evolution left its mark, the authors note.
To conduct the research, the team used sighting data for the species in all 58 Californian counties between 1938 and 2019, in addition to analyzing specimens preserved in museums. They also turned to old newspaper advertisements to estimate the number of feeders in use during the last century. Finally, they developed a computational model to predict hummingbird expansion, taking into account assisted feeding and the presence of eucalyptus trees.
An Anna's hummingbird in flight.'They seem to be moving where we are going and changing quite rapidly to succeed in their new environments. We can think of the Anna's hummingbird as a commensal species, similar to pigeons,' says Nicolas Alexandre, coauthor of the study and a geneticist at Colossal Biosciences, a biotechnology and de-extinction company based in Dallas, Texas.
Hummingbird feeders or drinkers use sugar water to attract hummingbirds and provide food during seasons when flower nectar is scarce. According to the journal Science, one of the oldest records of these devices dates back to 1928, although they were probably in use much earlier. In general, they do not pose a risk to the species, as long as they are cleaned regularly to avoid the proliferation of bacteria and fungi that can affect hummingbirds.
Another species of bird, the common pigeon ( Columba livia ) has also adapted to living in cities. Pigeons can be found in urban spaces around the world, taking advantage of the plentiful nesting sites and food that cities have to offer. They exist in urban environments without having a significant impact on human activities, this being a clear example of commensalism, where one species gains advantages by linking with another without directly harming it.
Columba livia originally inhabited rocky areas of Europe, Asia, and North Africa. However, it was domesticated more than 5,000 years ago as a source of food and due to its excellent sense of direction, which meant the birds could be used for carrying written messages. As a result, many were released into new habitats, with some choosing to live in cities, becoming part of the urban fauna. Today, they are one of the most common birds in the world.
This story originally appeared on WIRED en Español and has been translated from Spanish.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA's New AI Tool Cuts Review Time From 3 Days To 6 Minutes
FDA's New AI Tool Cuts Review Time From 3 Days To 6 Minutes

Forbes

time33 minutes ago

  • Forbes

FDA's New AI Tool Cuts Review Time From 3 Days To 6 Minutes

AI at the FDA getty The U.S. Food and Drug Administration announced this week that it deployed a generative AI tool called ELSA (Evidence-based Learning System Assistant), across its organization. After a low-profile pilot that delivered measurable gains, the system is now in use by staff across the agency, several weeks ahead of its original schedule. Dr. Marty Makary, the FDA's commissioner, shared a major outcome. A review task that once took two or three days now takes six minutes. 'Today, we met our goal ahead of schedule and under budget,' said Makary. 'What took one scientific reviewer two to three days [before] The FDA has thousands of reviewers, analysts, and inspectors who deal with massive volumes of unstructured data such as clinical trial documents, safety reports, inspection records. Automating any meaningful portion of that stack creates outsized returns. ELSA helps FDA teams speed up several essential tasks. Staff are already using it to summarize adverse event data for safety assessments, compare drug labels, generate basic code for nonclinical database setup, and identify priority sites for inspections, among other tasks. This last item, using data to rank where inspectors should go, could have a real-world impact on how the FDA oversees the drug and food supply chain and impacts on how the FDA delivers its services. Importantly, however, the tool isn't making autonomous decisions without a human in the loop. The system prepares information so that experts can decide faster. It cuts through the routine, not the judgment. One of the biggest questions about AI systems in the public sector revolves around the use of data and third party AI systems. Makary addressed this directly by saying that 'All information stays within the agency. The AI models are not being trained on data submitted by the industry.' That's a sharp contrast to the AI approaches being taken in the private sector, where many large language models have faced criticism over training on proprietary or user-submitted content. In the enterprise world, this has created mounting demand for "air-gapped" AI solutions that keep data locked inside the company. That makes the FDA's model different from many corporate tools, which often rely on open or external data sources. The agency isn't building a public-facing product. It's building a controlled internal system, one that helps it do its job better. Federal departments have been slow to move past AI experimentation. The Department of Veterans Affairs has started testing predictive tools to manage appointments. The SEC has explored market surveillance AI for years. But few have pushed into full and widespread production. The federal government has thousands of employees processing huge volumes of information, most of it unstructured sitting in documents, files, and even paper. That means AI is being focused most on operational and process-oriented activities. It's shaping up to be a key piece of how agencies process data, make recommendations, and act. Makary put it simply that ELSA is just the beginning for AI adoption within the FDA. 'Today's rollout of ELSA will be the first of many initiatives to come,' he said. 'This is how we'll better serve the American people.'​​

A Biotech Start-Up Promises Immortality. Is It All a Fraud?
A Biotech Start-Up Promises Immortality. Is It All a Fraud?

New York Times

time43 minutes ago

  • New York Times

A Biotech Start-Up Promises Immortality. Is It All a Fraud?

NOTES ON INFINITY, by Austin Taylor In Austin Taylor's debut, 'Notes on Infinity,' the campus novel is reimagined as a start-up fairy tale: Two college students from different worlds meet, spend their days and nights enjoying a heady exchange of ideas, drop out of school, found a wildly successful company, and flame out in scandal. Zoe, a driven and polished undergraduate chemist at Harvard, takes up with Jack, who at first seems to be a flaky genius in the grand tradition. Together they hatch an idea for prolonging human life, and name their biotech company Manna. One of them is keeping secrets, however, and the speed of their success doesn't allow either the time or inclination to reflect. Readers will see Theranos and a bit of FTX in the novel's inspiration, allusions that serve to dramatize the psychology of ambition and denial, how fraud can begin as a desperate, temporary fix, and then grow as the cost of the deception builds and builds. Taylor doesn't make her founders' initial lie explicit until after their fall from grace, leaving the reader to suspect that the whole business has to be rotten but not knowing exactly how or where. Mostly the pages turn themselves, but at times the familiarity of the plot can be grating. This is the challenge of basing any narrative on current events: When you think you know where a story is going, it's harder to see the characters as people. The messy, complex bond between Zoe and Jack gives the events greater texture and dimension, though: They lie to protect not just themselves, but each other. In this campus novel, the allure of tech entrepreneurship has altered the social hierarchy, to a point. Jack is befriended by a rich student named Carter, whom he later overhears justifying their relationship to his rich friends as they place bets on which of their awkward, outsider classmates will be 'the next Zuck.' When your peers place bets on your future, you become not a friend, but an instrument of their strategy. After some initial throat clearing, Taylor's fast-paced writing captures the pressure of start-up culture, and the ease with which a founder can be separated from their own creation. Zoe and Jack divvy up their responsibilities to match their perceived talents: Jack as the chaotic scientist, Zoe as the articulate, organized and elegant face of Manna. All public scrutiny will fall on her, while Jack will enjoy the benefits of the tech visionary stereotype. This fits neatly with their respective upbringings: Zoe's father is an M.I.T. professor and her mother is the renowned hostess of his 'living room seminars,' where 6-year-old Zoe 'would sometimes answer one of his rhetorical questions or proposals in a small, high voice: 'Your reasoning sounds flawed,' or 'Did you check your math there, Daddy?' Everyone thought this was adorable.' Jack grew up poor and neglected in central Maine; Harvard is his chance to escape, until he wants to escape it, too. Want all of The Times? Subscribe.

At City Ballet, Casting, Coaching and Dances Worth Watching
At City Ballet, Casting, Coaching and Dances Worth Watching

New York Times

time44 minutes ago

  • New York Times

At City Ballet, Casting, Coaching and Dances Worth Watching

Looks can be deceiving, even in ballet. On paper, the spring season of New York City Ballet looked safe and dutiful, with no premieres, except the stage performance of a pandemic-era dance film and more recent contemporary works, some welcome (by Alexei Ratmansky), others not so much (everything else). But the season had a surprising sense of purpose, which came from casting, coaching and commendable repertoire. Suzanne Farrell, the former City Ballet star, worked with the dancers on four ballets. The 50th anniversary of the Ravel Festival made for a memorable trip back to 1975. And debuts were plentiful; more than that, they were meaningful choices, the kinds of roles that challenge dancers at the right time and give them the space to grow. Ratmansky didn't need to present a premiere. Two sides of his artistry were already on display. There was the buoyant, technical 'Paquita,' his spirited look at classicism in the 21st century; and 'Solitude,' a remarkable ballet illustrating the inner turmoil and outer tragedy of the war in Ukraine, with dancing shaped by and seeped in sorrow. It is even stronger now — quietly devastating with an icy spareness and, from the dancers, deep, grounded conviction. Its placement on a program between Caili Quan's 'Beneath the Tides' and Justin Peck's 'Mystic Familiar' seemed clueless, as if all of contemporary ballet is on an equal playing field. It's not. Other programs were dragged down by ballets that felt like needless filler — Peck's blandly lush 'Belles-Lettres' and Christopher Wheeldon's drippy 'After the Rain' pas de deux. The pas de deux made what should have been a strong program of ballets by Jerome Robbins and Ratmansky interminable. Ballet is an art, but its athletic demands can be cruel: Gilbert Bolden III, a new, much-valued principal dancer, tore his Achilles during a performance of 'Scotch Symphony.' His recovery will take months. But that show went on — Jules Mabie filled in for him — and the season, which included a farewell to the longtime principal Andrew Veyette, ended on a cheerful note with Balanchine's enchanting 'A Midsummer Night's Dream,' made even more so by the debut of Mira Nadon, dancing with Peter Walker, in the second act divertissement. She moves like silk. Here are a few other standout ballets and performances. Kyle Abraham Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store